Phil B Alper

6PUBLICATIONS
16CO-AUTHORS
Biomolecular modelling and designInnate immunityAutoimmunityNatural products and bioactive compoundsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 10, 2026
Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.

|May 19, 2026
Targeting Multiple KRAS Mutations with High-Affinity Macrocyclic Inhibitors: From Discovery to Preclinical Validation.

|Aug 16, 2023
Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune Diseases.

Phil Alper, Claudia Betschart, Cédric André

|Aug 14, 2020
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.

Thomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier

|Dec 22, 2017
Photoinduced Rearrangement of Dienones and Santonin Rerouted by Amines.

Zhipeng Zhang, Maxim Ratnikov, Glen Spraggon

|Nov 18, 2017
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).

David C Tully, Paul V Rucker, Donatella Chianelli

Pageof 1

Frequent Collaborators

2 joint publications

Thomas Knoepfel

2 joint publications

Dean P Phillips

2 joint publications

Sarah E Kochanek

2 joint publications

Michael DiDonato